Validated machine-based learning model performs better than surgeons, radiologists, CADx for predicting malignancy
Cosela reduces the frequency of bone marrow suppression caused by chemotherapy for extensive-stage small cell lung cancer
Blacks more likely to present at advanced stage, less likely to receive surgery, have higher mortality at higher residential segregation levels
Findings seen despite the U.S. Preventive Services Task Force revised eligibility criteria
Once operations resumed, decrease seen in new patients screened, proportion of suspicious nodules increased
Current approval of the once-daily tablet indicated for patients who have undergone complete tumor removal
Increased risks persist beyond six months for patients with lung cancer receiving PD1i and with malignant melanoma receiving CTLA-4i<strong></strong>
Risk varies according to profile of the oral microbiota; risk lower with greater abundance of <em>Spirochaetia</em>, <em>Bacteroidetes</em>
Mutation frequencies of <em>EGFR</em> and <em>KRAS</em> were 30 and 10 percent, respectively, and 23 and 13 percent, respectively, for Mexican and Colombian patients
Restricted mean survival time difference was 0.84 years at 10 years for women undergoing pulmonary resection<strong></strong>